US provides Ebola treatment for outbreak in Congo, bringing trials closer
The US is providing experimental Ebola treatments for an outbreak in Congo, accelerating clinical trials.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
📍 How it ended
The U.S. provided experimental Ebola treatments and committed $50 million to develop countermeasures for the Bundibugyo strain in the Democratic Republic of Congo. The WHO announced two trials of experimental drugs, including antivirals from Mapp and Gilead.
The WHO later stated that the response to the outbreak began to bear fruit.
Epilogue added 10d ago, after coverage quieted.
The brief
The US has provided experimental Ebola treatments for an outbreak in the Democratic Republic of Congo. This move brings clinical trials closer, with two experimental drugs set to be tested. Coverage from Reuters and NBC News highlights the US's provision of treatments, while sources like CIDRAP and Medical Xpress detail the upcoming trials.
The Straits Times and Global Biodefense report on advocacy efforts and funding commitments. The WHO has announced trials for experimental drugs, with the US committing $50 million to develop countermeasures. Trials are expected to start soon, involving antivirals from Mapp and Gilead.
Advocacy groups are urging the US to share experimental drugs for these trials. Watch for updates on the commencement of trials and the progress of the outbreak. Coverage does not yet specify the exact start date or the scale of the trials.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 19d ago.
Quick answers
What treatments are being provided by the US?
The US is providing experimental Ebola treatments, specifically antivirals from Mapp and Gilead.
When will the trials start?
Coverage does not yet specify the exact start date for the trials.
How much funding has the US committed?
The US has committed $50 million to develop countermeasures for the Bundibugyo Ebola strain.
Coverage (12)
- WHO: Response to Ebola Outbreak in Democratic Republic of Congo Begins to Bear Fruit وكالة سبأ · 23d ago
- WHO announces 2 trials of experimental drugs in Ebola outbreak CIDRAP · 23d ago
- U.S. Commits $50 Million to Develop Countermeasures for Bundibugyo Ebola Strain Amid Growing DRC Outbreak Global Biodefense · 23d ago
- Advocacy groups urge US to share experimental Ebola drug for outbreak trials The Straits Times · 23d ago
- HHS has sent drug for Ebola clinical trial statnews.com · 23d ago
- Trials of two Ebola treatments to start in DRC next week: WHO Medical Xpress · 23d ago
- Mapp, Gilead antivirals to be deployed in DRC Ebola trial: WHO chief Fierce Biotech · 23d ago
- As Ebola Cases Breach 1000, Trial Of Two Antiviral Treatments Due To Start Soon Health Policy Watch · 23d ago
- Experts urge use of experimental antibodies in DR Congo to combat Ebola CIDRAP · 23d ago
- Clinical trial set to test two drugs for fast-growing Ebola outbreak statnews.com · 23d ago
- U.S. provides experimental Ebola treatment for outbreak in Congo, bringing trials closer NBC News · 23d ago
- US provides Ebola treatment for outbreak in Congo, bringing trials closer Reuters · 23d ago
Topics
Related trends
Ebola spreading more quickly in DRC, while Uganda is close to being virus-free
Ebola's rapid spread in the DRC contrasts with Uganda's progress towards eliminating the virus.
“He’s a 1,000kg wild marine predator that is very capable of hurting someone if startled.” Who is Neil the seal?
4 news sources are covering this World story right now — Archynetys is tracking how fast it spreads.
Up to 45% of dementia risk can be prevented, delayed: WHO
6 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
Ebola outbreak: Uganda starts 42-day countdown to being declared free of the virus
Uganda has entered a 42-day countdown to be declared free of Ebola after discharging its final patient.
New monkey species with orange lips found 'hiding' in DRC forest
Researchers have identified a new species of monkey, distinguished by its unique orange lips, deep within the forests of the Democratic Republic of Congo.
Loneliness strongly linked to poorer mental health and well-being, study finds
Emerging research links social isolation to significant declines in mental health, physical well-being, and increased risks of serious chronic disease.